| Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective E Ramelyte, A Tastanova, Z Balázs, D Ignatova, P Turko, U Menzel, ... Cancer cell 39 (3), 394-406. e4, 2021 | 81 | 2021 |
| Synthetic biology-based cellular biomedical tattoo for detection of hypercalcemia associated with cancer A Tastanova, M Folcher, M Müller, G Camenisch, A Ponti, T Horn, ... Science translational medicine 10 (437), eaap8562, 2018 | 63 | 2018 |
| A comparative study of real-time RT-PCR–based SARS-CoV-2 detection methods and its application to human-derived and surface swabbed material A Tastanova, CI Stoffel, A Dzung, PF Cheng, E Bellini, P Johansen, ... The Journal of Molecular Diagnostics 23 (7), 796-804, 2021 | 29 | 2021 |
| Overexpression of YY1 increases the protein production in mammalian cells A Tastanova, A Schulz, M Folcher, A Tolstrup, A Puklowski, H Kaufmann, ... Journal of biotechnology 219, 72-85, 2016 | 29 | 2016 |
| Prolonged unfrozen storage and repeated freeze-thawing of SARS-CoV-2 patient samples have minor effects on SARS-CoV-2 detectability by RT-PCR A Dzung, PF Cheng, C Stoffel, A Tastanova, P Turko, MP Levesque, ... The Journal of Molecular Diagnostics 23 (6), 691-697, 2021 | 21 | 2021 |
| An optimized tissue dissociation protocol for single-cell RNA sequencing analysis of fresh and cultured human skin biopsies B Burja, D Paul, A Tastanova, SG Edalat, R Gerber, M Houtman, M Elhai, ... Frontiers in Cell and Developmental Biology 10, 872688, 2022 | 19 | 2022 |
| ROS induction targets persister cancer cells with low metabolic activity in NRAS-mutated melanoma OM Eichhoff, CI Stoffel, J Käsler, L Briker, P Turko, G Karsai, N Zila, ... Cancer Research 83 (7), 1128-1146, 2023 | 7 | 2023 |
| Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells A Amaro, F Reggiani, D Fenoglio, R Gangemi, A Tosi, A Parodi, B Banelli, ... Journal of Experimental & Clinical Cancer Research 42 (1), 67, 2023 | 6 | 2023 |
| Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq G Restivo, A Tastanova, Z Balázs, F Panebianco, M Diepenbruck, ... Communications Biology 5 (1), 1144, 2022 | 6 | 2022 |
| Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma U Lischetti, A Tastanova, F Singer, L Grob, M Carrara, PF Cheng, ... Communications Biology 6 (1), 830, 2023 | 4 | 2023 |
| Collection and preprocessing of fine needle aspirate patient samples for single cell profiling and data analysis A Tastanova, E Ramelyte, Z Balázs, U Menzel, C Beisel, M Krauthammer, ... STAR protocols 2 (2), 100581, 2021 | 2 | 2021 |
| gExcite: a start-to-end framework for single-cell gene expression, hashing, and antibody analysis L Grob, A Bertolini, M Carrara, U Lischetti, A Tastanova, C Beisel, ... Bioinformatics 39 (5), btad329, 2023 | 1 | 2023 |
| Prolonged Unfrozen Storage and Repeated Freeze-Thawing of Severe Acute Respiratory Syndrome Coronavirus 2 Patient Samples Have Minor Effects on Severe Acute Respiratory … A Dzung, PF Cheng, C Stoffel, A Tastanova, P Turko, MP Levesque, ... Journal of Molecular Diagnostics 23 (6), 691-697, 2021 | 1 | 2021 |
| Label-free melanoma phenotype classification using AI-based morphological profiling E Lattmann, A Jovic, J Kim, A Tastanova, T Pham, C Corona, K Saini, ... Cancer Research 84 (6_Supplement), 4306-4306, 2024 | | 2024 |
| Integrated transcriptomics reveals cellular and molecular interactions in pruritic cutaneous T-cell lymphoma A Roggo, A Ghosh, P Turko, M Nägeli, E Ramelyte, MP Levesque, ... EJC Skin Cancer 2, 100067, 2024 | | 2024 |
| Multiomics analysis reveals a Type III driven immune response in immunotherapy-induced toxicity in melanoma and identifies potential new therapeutic targets M Levesque, F Dimitriou, P Cheng, A Saltari, K Schaper-Gerhardt, ... | | 2023 |
| 1607 Multiomic analysis of immune-related adverse events (irAEs) in melanoma patients treated with anti-PD1-based immune checkpoint inhibitors (ICIs) F Dimitriou, P Cheng, A Saltari, R Staeger, A Tastanova, M Levesque, ... Journal of Investigative Dermatology 143 (5), S275, 2023 | | 2023 |
| High dimensional morphology analysis reveals new insights in melanoma cell heterogeneity E Lattmann, A Tastanova, A Jovic, K Saini, T Pham, C Corona, J Mei, ... Cancer Research 83 (7_Supplement), 5926-5926, 2023 | | 2023 |
| 243P Skin biopsies for pharmacodynamic studies of tebentafusp: A novel bispecific molecule against the melanocytic antigen gp100 R Stäger, A Tastanova, E Ramelyte, MP Levesque, R Dummer, ... Immuno-Oncology and Technology 16, 2022 | | 2022 |
| ROS induction as a strategy to target persister cancer cells with low metabolic activity in NRAS mutated melanoma OM Eichhoff, CI Stoffel, J Käsler, L Briker, P Turko, G Karsai, N Zila, ... bioRxiv, 2022.10. 19.512839, 2022 | | 2022 |
